💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Insmed, Inc. (INSM)
« Back to company indexINSM Chatter Timeline
Stock Ticker for INSM
Most Active Tweeters for INSM
| User | Tweets |
|---|---|
| @formwhisperscom | 5 |
| @mehabecapital | 5 |
| @mediasentiment | 4 |
| @Tickeron | 4 |
| @TradeWithAlerts | 2 |
Recent Tweets for INSM
 |
@ShortAlgoTrades $INSM Waiting for Buy signal. Chart by https://t.co/jpmUt7BvVp https://t.co/ASW0Ux6ujt January 24th 2022, 5:01pm |
 |
@ShogunTrade $INSM Awaiting Buy Signal. Chart by https://t.co/6vnULU2sSf https://t.co/Oz58cTOkN9 January 24th 2022, 11:01am |
 |
@TradingChromat1 Awaiting Buy signal on $INSM https://t.co/Ly3JvALYqx January 21st 2022, 6:01pm |
 |
@AlertTrade MOST ACTIVE: $INSM Insmed, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ January 21st 2022, 3:01pm |
 |
@PenkeTrading I found you a Death Cross on the daily chart of Insmed Incorporated. $INSM $INSM.NASDAQ #deathcross #bearish… https://t.co/H4Q8aGnQoD January 21st 2022, 1:01pm |
 |
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1096 January 20th 2022, 10:01pm |
|
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1095 January 20th 2022, 10:01pm |
 |
@LargeVoidBot Daily Reversal (10:31): $INSM Last: 23.22; pHigh: 23.21; rVol: 0.778; pClose: 22.22; LOD: 22.6700; Perf: 4.5% January 20th 2022, 3:01pm |
 |
@TradeFlags #DeathCross $INSM at 22.22 R21 T1Y 53 buy 1.8 DIV N/A #Insmed Inc #stocks #trading #finance #market https://t.co/YSzrUHo23Z January 20th 2022, 3:01am |
 |
@InvestorVillage Trending: $INSM ongoing drug trials; potential market sizes; upcoming Phase 2a TPIP (Treprostinil Palmitil Inhalat… https://t.co/QELkra0Mk1 January 18th 2022, 4:01pm |
 |
@invescent $INSM Data indicates that the overall analyst sentiment for INSM is neutral Simplify the way you research stocks… https://t.co/9CBgzSEH7j January 18th 2022, 2:01am |
 |
@A1Syad $INSM Bullish pattern building. Chart by https://t.co/1MjnDHV7ua https://t.co/nntnrdjiUL January 17th 2022, 4:01pm |
|
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 170 January 17th 2022, 3:01am |
 |
@Tickeron 6 Insiders at Insmed sold 8,071 shares last week for $202.0K $INSM #Insmed #stockmarket #stock https://t.co/fLtD22H0Xf January 17th 2022, 3:01am |
|
@invescent $INSM Data indicates that the overall analyst sentiment for INSM is neutral Simplify the way you research stocks… https://t.co/qCsjU5cNuZ January 17th 2022, 12:01am |
|
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 135 January 15th 2022, 12:01pm |
|
@TradingChromat1 Awaiting Buy signal on $INSM https://t.co/LYxe831FNW January 14th 2022, 10:01pm |
 |
@TradeWithAlerts Nice print for $INSM Size: 145240 Price: 23.73 Amount: $3,446,545.20 Time: 1600 See more: https://t.co/T32Lqg3haE J… https://t.co/CfXu6ETbL1 January 14th 2022, 9:01pm |
|
@TradeWithAlerts Nice print for $INSM Size: 180000 Price: 23.55 Amount: $4,239,000.00 Time: 1546 See more: https://t.co/T32Lqg3haE J… https://t.co/iiWUz9gaiC January 14th 2022, 8:01pm |
|
@Tickeron $INSM was the month's biggest loser, descending -11.74% #Insmed #stockmarket #stock https://t.co/xJqNHfFHZC January 14th 2022, 4:01pm |
|
@Tickeron $INSM enters a Downtrend because Momentum Indicator dropped below the 0 level on January 5, 2022. View odds for thi… https://t.co/M0fQkCCBsC January 14th 2022, 3:01pm |
 |
@newsfilterio $72,141.03 of shares sold by Lewis William (Chair and CEO), reported in a new form 4 filed with the SEC $INSM https://t.co/ojXlUJUeY3 January 14th 2022, 5:01am |
|
@Tickeron $INSM's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/GKfc2AzS0m January 14th 2022, 3:01am |
 |
@mehabecapital Insider Activity seen in $INSM, Flammer Martina M.D. (Chief Medical O) Sale, Total-Shares = 1,495, Transaction Pri… https://t.co/pJWsO49eBs January 13th 2022, 9:01pm |
|
@mehabecapital Insider Activity seen in $INSM, Adsett Roger (Chief Operating) Sale, Total-Shares = 1,217, Transaction Price= $24.… https://t.co/zIAbx8QcDD January 13th 2022, 9:01pm |
|
@mehabecapital Insider Activity seen in $INSM, Schaeffer Orlov S Ni (Chief People St) Sale, Total-Shares = 925, Transaction Price… https://t.co/Jgbyj9Uv6z January 13th 2022, 9:01pm |
|
@mehabecapital Insider Activity seen in $INSM, Smith Michael Alexan (General Counsel) Sale, Total-Shares = 407, Transaction Price… https://t.co/wvaXYBIBLT January 13th 2022, 9:01pm |
|
@mehabecapital Insider Activity seen in $INSM, Lewis William (Chair and CEO) Sale, Total-Shares = 2,873, Transaction Price= $25.1… https://t.co/bT6MlT7CDJ January 13th 2022, 9:01pm |
 |
@formwhisperscom #FWSells $INSM Schaeffer Orlov S Nicole, Chief People Strategy Officer of INSMED Inc sold 925 shares on 2022-01-11. https://t.co/R2WUpafMCS January 13th 2022, 9:01pm |
|
@formwhisperscom #FWSells $INSM Lewis William, Chair and CEO of INSMED Inc sold 2,873 shares on 2022-01-11. https://t.co/R2WUpafMCS January 13th 2022, 9:01pm |
|
@formwhisperscom #FWSells $INSM Adsett Roger, Chief Operating Officer of INSMED Inc sold 1,217 shares on 2022-01-12. https://t.co/R2WUpafMCS January 13th 2022, 9:01pm |
|
@formwhisperscom #FWSells $INSM Bonstein Sara, Chief Financial Officer of INSMED Inc sold 1,154 shares on 2022-01-11. https://t.co/R2WUpafMCS January 13th 2022, 9:01pm |
|
@formwhisperscom #FWSells $INSM Flammer Martina M.D., Chief Medical Officer of INSMED Inc sold 1,495 shares on 2022-01-11. https://t.co/R2WUpafMCS January 13th 2022, 9:01pm |
 |
@ShortAlgoKing $INSM Almost ripe for a jump! Chart by https://t.co/qchl9O5K2n https://t.co/uKTdPT6g9T January 13th 2022, 9:01pm |
|
@A1Syad $INSM Awaiting Buy Signal. Free Trial at https://t.co/1MjnDHV7ua https://t.co/lsdA23bvq1 January 13th 2022, 2:01pm |
 |
@Gambiste1 RT @kkernttb: $INSM nice example of short setup and breakdown https://t.co/o9MCENsIUs January 12th 2022, 11:01pm |
 |
@kkernttb $INSM nice example of short setup and breakdown https://t.co/o9MCENsIUs January 12th 2022, 10:01pm |
 |
@SismasStock $INSM waiting for Buy signal on INSM with https://t.co/WNHrn3Pr7t https://t.co/PJ0TrqxVfE January 12th 2022, 5:01pm |
 |
@Ba4Saso $INSM Awaiting Buy Signal. Stock Trading Ideas by https://t.co/z6vAd7dl0q https://t.co/tjk3wpqUOm January 12th 2022, 2:01pm |
|
@SismasStock $INSM waiting for Buy signal on INSM with https://t.co/WNHrn3Pr7t https://t.co/2OTFIVVBSk January 11th 2022, 10:01pm |
|
@TradeWithAlerts Nice print for $INSM Size: 193147 Price: 24.59 Amount: $4,749,484.73 Time: 1600 See more: https://t.co/T32LqglqoM J… https://t.co/oexOP0CBXX January 11th 2022, 9:01pm |
|
@TradingChromat1 Awaiting Buy signal on $INSM https://t.co/Djw1bbNU8D January 11th 2022, 8:01pm |
 |
@OptionHunt Ticker $INSM Unusual Volume Detected: 39.10% over average January 11th 2022, 5:01pm |
 |
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Financial Officer SARA BONSTEIN: https://t.co/uB4cWCdoAY January 11th 2022, 1:01pm |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chair and CEO WILLIAM LEWIS: https://t.co/muaSpxGHho January 11th 2022, 11:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Medical Officer MARTINA M.D. FLAMMER: https://t.co/BgyblnwilS January 11th 2022, 11:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's General Counsel, Senior VP MICHAEL ALEXANDER SMITH: https://t.co/bFBAz0LNGk January 11th 2022, 7:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief Operating Officer ROGER ADSETT: https://t.co/b7d9DcrDdG January 11th 2022, 7:01am |
|
@InsiderAlerts4U $INSM: New Insider Filing on INSMED Inc's Chief People Strategy Officer ORLOV S NICOLE SCHAEFFER: https://t.co/9PZb33zQDn January 11th 2022, 3:01am |
|
@mediasentiment $INSM new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 730 January 10th 2022, 11:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?